Cargando…

Migraine-specific quality of life questionnaire and relapse of medication overuse headache

BACKGROUND: The management of Medication overuse headache (MOH) represents a difficult challenge for clinicians and headache experts, particularly for the responder rate after a successful withdrawal treatment. The purpose of this study was to investigate the role of demographic and clinical charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caproni, Stefano, Bianchi, Elisa, Cupini, Letizia M., Corbelli, Ilenia, Beghi, Ettore, Calabresi, Paolo, Sarchielli, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460700/ https://www.ncbi.nlm.nih.gov/pubmed/25991008 http://dx.doi.org/10.1186/s12883-015-0339-8

Ejemplares similares

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2014)

HDAC3 role in medication consumption in medication overuse headache patients: a pilot study
por: Pisanu, Claudia, et al.
Publicado: (2015)

Drug-dependence behaviour and outcome of medication-overuse headache after treatment
por: Corbelli, Ilenia, et al.
Publicado: (2012)

Immunological findings in patients with migraine and other primary headaches: a narrative review
por: Biscetti, Leonardo, et al.
Publicado: (2021)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

Migraine with aura in the locker room: three case reports
por: Corbelli, Ilenia, et al.
Publicado: (2011)

Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms
por: Biscetti, Leonardo, et al.
Publicado: (2021)

Dural arteriovenous fistulas and headache features: an observational study
por: Corbelli, Ilenia, et al.
Publicado: (2020)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine
por: Sarchielli, Paola, et al.
Publicado: (2017)

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
por: Romoli, Michele, et al.
Publicado: (2015)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Cortical spreading depression as a target for anti-migraine agents
por: Costa, Cinzia, et al.
Publicado: (2013)

P066. Migraine with aura in the locker room: 4 case reports
por: Bernetti, Laura, et al.
Publicado: (2015)

Theory of Mind in migraine and medication-overuse headache: A cross-sectional study
por: Romozzi, Marina, et al.
Publicado: (2022)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks
por: Coppola, Gianluca, et al.
Publicado: (2022)

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
por: Limberg, Nicole
Publicado: (2023)

Effects of smartphone overuse on headache, sleep and quality of life in migraine patients
por: Demir, Yasemin P., et al.
Publicado: (2019)

Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist
por: Sarchielli, P., et al.
Publicado: (2005)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
por: Genizi, Jacob, et al.
Publicado: (2023)

Trigger factors of migraine and tension-type headache
por: Sarchielli, P.
Publicado: (2006)

Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC)
por: Gallai, Virgilio, et al.
Publicado: (2001)

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
por: Cevoli, Sabina, et al.
Publicado: (2017)

Temperament and character profiles of patients with chronic migraine and medication-overuse headache
por: Watanabe, Y, et al.
Publicado: (2013)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
por: Martelletti, Paolo
Publicado: (2018)

Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache
por: Wang, Yen-Feng, et al.
Publicado: (2023)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Distinct Food Triggers for Migraine, Medication Overuse Headache and Irritable Bowel Syndrome
por: Ceren Akgor, Merve, et al.
Publicado: (2023)

Predictive factors for the relapse medication overuse headache. A prospective study
por: Sergeev, A, et al.
Publicado: (2013)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

The value of epidemiology in headache
por: Beghi, Ettore
Publicado: (2015)

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
por: Corbelli, Ilenia, et al.
Publicado: (2022)

Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
por: Gracia-Naya, M, et al.
Publicado: (2013)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly’s Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City—Itoigawa Hisui Study
por: Katsuki, Masahito, et al.
Publicado: (2022)

The evolving classifications and epidemiological challenges surrounding chronic migraine and medication overuse headache: a review
por: Schembri, Emanuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e502ev4n2c0prq90qjjbs4cud7